These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 25433652)

  • 21. Early warning indicators for HIV drug resistance in adults in South Africa at 2 pilot sites, 2008-2010.
    Dube NM; Tint KS; Summers RS
    Clin Infect Dis; 2014 Jun; 58(11):1607-14. PubMed ID: 24585566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Highly active antiretroviral therapy: physician experience and enhanced adherence to prescription refill.
    Delgado J; Heath KV; Yip B; Marion S; Alfonso V; Montaner JS; O'Shaughnessy MV; Hogg RS
    Antivir Ther; 2003 Oct; 8(5):471-8. PubMed ID: 14640395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of different patterns of nonadherence on the outcome of highly active antiretroviral therapy in patients with long-term follow-up.
    Knobel H; Urbina O; González A; Sorlí ML; Montero M; Carmona A; Guelar A
    HIV Med; 2009 Jul; 10(6):364-9. PubMed ID: 19490179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adherence to tablet and liquid formulations of antiretroviral medication for paediatric HIV treatment at an urban clinic in Uganda.
    Bagenda A; Barlow-Mosha L; Bagenda D; Sakwa R; Fowler MG; Musoke PM
    Ann Trop Paediatr; 2011; 31(3):235-45. PubMed ID: 21781419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
    Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
    BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors before enrolment are associated with being removed from a Pharmacy-only Refill Programme at a large urban HIV/AIDS clinic, Uganda.
    Nakiwogga-Muwanga A; Katabira E; Kiragga A; Kambugu A; Nakibuuka-Lubwama E; Manabe YC; Alamo ST; Colebunders R
    Int J STD AIDS; 2014 Feb; 25(2):105-12. PubMed ID: 23970633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Very early virological failure and drug resistance mutations in a woman on antiretroviral therapy in Eastern Cape, South Africa: a case report.
    Sogbanmu OO; Adeniyi OV; Fuentes YO; Ter Goon D
    J Med Case Rep; 2015 May; 9():106. PubMed ID: 25947544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time patterns of adherence and long-term virological response to non-nucleoside reverse transcriptase inhibitor regimens in the Stratall ANRS 12110/ESTHER trial in Cameroon.
    Meresse M; Carrieri MP; Laurent C; Kouanfack C; Protopopescu C; Blanche J; Cohen J; Laborde-Balen G; Aghokeng AF; Spire B; Moatti JP; Delaporte E; Boyer S;
    Antivir Ther; 2013; 18(1):29-37. PubMed ID: 23358393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Role of Pharmacy Refill Measures in Assessing Adherence and Predicting HIV Disease Markers in Youth with Perinatally-Acquired HIV (PHIV).
    Yildirim C; Garvie PA; Chernoff M; Wilkins ML; Patton ED; Williams PL; Nichols SL;
    AIDS Behav; 2019 Aug; 23(8):2109-2120. PubMed ID: 30929147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adherence to antiretroviral therapy in pediatric patients with human immunodeficiency virus (HIV-1).
    Burack G; Gaur S; Marone R; Petrova A
    J Pediatr Nurs; 2010 Dec; 25(6):500-4. PubMed ID: 21035017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medication refill logistics and refill adherence in HIV.
    Gross R; Zhang Y; Grossberg R
    Pharmacoepidemiol Drug Saf; 2005 Nov; 14(11):789-93. PubMed ID: 15880515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of a pharmacy-based health literacy intervention and patient characteristics on medication refill adherence in an urban health system.
    Gazmararian J; Jacobson KL; Pan Y; Schmotzer B; Kripalani S
    Ann Pharmacother; 2010 Jan; 44(1):80-7. PubMed ID: 20028960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Virological failure after 1 year of first-line ART is not associated with HIV minority drug resistance in rural Cameroon .
    Zoufaly A; Jochum J; Hammerl R; Nassimi N; Raymond Y; Burchard GD; Schmiedel S; Drexler JF; Campbell NK; Taka N; Awasom C; Metzner KJ; van Lunzen J; Feldt T
    J Antimicrob Chemother; 2015 Mar; 70(3):922-5. PubMed ID: 25428920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes of nevirapine- and efavirenz-based antiretroviral therapy when coadministered with rifampicin-based antitubercular therapy.
    Boulle A; Van Cutsem G; Cohen K; Hilderbrand K; Mathee S; Abrahams M; Goemaere E; Coetzee D; Maartens G
    JAMA; 2008 Aug; 300(5):530-9. PubMed ID: 18677025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Utility of Pharmacy-Based Adherence Measurement in Predicting Virologic Outcomes in an Adult HIV-Infected Cohort in Jos, North Central Nigeria.
    Abah IO; Ojeh VB; Musa J; Ugoagwu P; Agaba PA; Agbaji O; Okonkwo P
    J Int Assoc Provid AIDS Care; 2016; 15(1):77-83. PubMed ID: 24963086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacy Refill Data are Poor Predictors of Virologic Treatment Outcomes in Adolescents with HIV in Botswana.
    Genn L; Chapman J; Okatch H; Abell N; Marukutira T; Tshume O; Anabwani G; Gross R; Lowenthal ED
    AIDS Behav; 2019 Aug; 23(8):2130-2137. PubMed ID: 30387024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Moving Antiretroviral Adherence Assessments to the Modern Era: Correlations Among Three Novel Measures of Adherence.
    Saberi P; Chakravarty D; Ming K; Legnitto D; Gandhi M; Johnson MO; Neilands TB
    AIDS Behav; 2020 Jan; 24(1):284-290. PubMed ID: 31758349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies.
    Braithwaite RS; Kozal MJ; Chang CC; Roberts MS; Fultz SL; Goetz MB; Gibert C; Rodriguez-Barradas M; Mole L; Justice AC
    AIDS; 2007 Jul; 21(12):1579-89. PubMed ID: 17630553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct monthly highly active antiretroviral therapy supply - a method to increase patient's adherence and outcome. Experience of one AIDS centre in Israel.
    Elbirt D; Asher I; Mahlev-Guri K; Bezalel-Rozenberg S; Werner B; Cohen Y; Sthoeger Z
    Int J STD AIDS; 2014 Jul; 25(8):579-86. PubMed ID: 24352126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.